Farallon Capital Management LLC Exelixis, Inc. Transaction History
Farallon Capital Management LLC
- $19.9 Billion
- Q3 2024
A detailed history of Farallon Capital Management LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Farallon Capital Management LLC holds 25,410,500 shares of EXEL stock, worth $859 Million. This represents 3.31% of its overall portfolio holdings.
Number of Shares
25,410,500
Previous 27,102,500
6.24%
Holding current value
$859 Million
Previous $609 Million
8.28%
% of portfolio
3.31%
Previous 2.95%
Shares
26 transactions
Others Institutions Holding EXEL
# of Institutions
502Shares Held
243MCall Options Held
2.54MPut Options Held
2.29M-
Black Rock Inc. New York, NY33.5MShares$1.13 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.3MShares$991 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.4MShares$519 Million0.63% of portfolio
-
State Street Corp Boston, MA11.4MShares$387 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL8.1MShares$274 Million0.45% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $10.9B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...